Reaching Others University at Buffalo - The State University of New York
Skip to Content
Teresa                         Quattrin

Teresa Quattrin MD

Department of Pediatrics

UB Distinguished Professor and Chair of Pediatrics
Chief, Endocrinology and Diabetes

Specialty/Research Focus

Pediatric Diabetes; Pediatric Endocrinology; Pediatrics

 
top-left cornertop-right corner

Education and Training:
  • Fellowship, Pediatric Endocrinology, University at Buffalo (1990)
  • Residency, Pediatrics, University at Buffalo (1989)
  • Fellowship, Pediatric Endocrinology, University at Buffalo (1988)
  • Fellowship, Pediatric Endocrinology, University at Buffalo (1986)
  • Residency, Pediatrics, University of Naples School of Medicine (1985)
  • Internship, Pediatrics, University of Naples School of Medicine (1983)
  • MD, Medicine, University of Naples School of Medicine, magna cum laude (1982)
Employment:
  • Distinguished Professor, University at Buffalo (2011-present)
  • Chair and A. Conger Goodyear Professor of Pediatrics, University at Buffalo (2010-present)
  • Pediatrician-in-Chief, Women and Children's Hospital of Buffalo (2010-present)
  • Professor, Pediatrics, University at Buffalo (2007-present)
  • Chief, Division of Endocrinology/Diabetes, Pediatrics, Women and Children's Hospital of Buffalo (2002-present)
  • Attending Physician, Division of Endocrinology/Diabetes, Pediatrics, Women and Children's Hospital of Buffalo (1990-present)
  • Interim Pediatrician-in-Chief, Women and Children's Hospital of Buffalo (2007–2010)
  • Interim Chair, University at Buffalo (2007–2010)
  • Director, Pediatric Endocrinology Fellowship Program, University at Buffalo (2002–2009)
  • Associate Professor, Pediatrics, University at Buffalo (1996–2007)
  • Director, Diabetes Center, Women and Children's Hospital of Buffalo (1990–2001)
  • Assistant Professor, Pediatrics, University at Buffalo (1990–1996)
  • Attending Physician, Emergency Room, Pediatrics, Women and Children's Hospital of Buffalo (1989–1990)
  • Research Assistant Professor, Pediatrics, University at Buffalo (1987–1988)
See All (14 Total) >
Awards and Honors:
  • Consumers‘ Checkbook: Top Doctor (2011)
  • University at Buffalo: Distinguished Professor (2011)
  • A. Conger Goodyear Endowed Chair (2010)
  • Best Doctors in America (2011-2012 )

Grants and Sponsored Research:
  • January 2011–January 2016
    The Western New York Project for Pediatric Obesity Prevention (WNYOPP)
    New York State Department of Health
    Role: Principal Investigator
    $500,000
  • December 2011–November 2014
    Anti-Diabetic Effects of Liraglutide in Adolescents and Young Subjects with Type 1 Diabetes
    American Diabetes Association
    Role: Co-Investigator
    $600,000
  • October 2011–March 2014
    Obesity Prevention in Pediatric Health Care Settings - COLA supplement
    NYS Department of Health
    Role: Principal Investigator
    $262,029
  • January 2010–January 2013
    T1D Exchange
    Leona M. and Harry B. Helmsley Charitable Trust
    Role: Co-Principal Investigator
  • April 2008–March 2012
    Treating Overweight Youth: A Family Based Approach in Primary Care
    NICHD
    Role: Principal Investigator
    $2,562,772
  • January 2011–January 2012
    Buffalo Healthy Tots Follow-up Program
    Wildermuth Research Foundation
    Role: Principal Investigator
    $25,000
  • October 2006–September 2011
    New York State Center of Excellence for Type 2 Diabetes
    New York State Department of Health
    Role: Principal Investigator
    $550,000
  • May 2006–June 2008
    Type 1 Diabetes TrialNet
    NIDDK
    Role: Principal Investigator
    $311,019
  • January 2002–January 2008
    Randomized, Placebo Based, Double-Blind Study Evaluating the Feasibility and Safety of ETANERCEPT Subcutaneous Administration in Pediatric Subjects with Type 1 Diabetes Mellitus to Prolong the Partial Remission Period
    Amgen
    Role: Principal Investigator
    $165,328
  • January 2004–January 2006
    Efficacy and Safety of Insulin Glulisine Compared to Insulin Lispro in Children and Adolescents with Type 1 Diabetes Mellitus: A 26 Week, Multi-Center, Open, Parallel, Clinical Trial
    Aventis
    Role: Principal Investigator
    $36,300
  • January 2004–January 2006
    Recombinant Human Insulin-like Growth Factor-1 (rhIGF-1) Treatment of Prepubertal Children with Growth Failure Associated with Primary IGF-1 Deficiency: A Phase 3, Randomized, Open-Label, Observation-Controlled, Multicenter, Parallel-Dose Comparison Tria
    Tercica
    Role: Principal Investigator
    $7,500
  • January 2004–January 2005
    External Continuous Subcutaneous Infusion of Insulin Aspart (Novolog) versus Insulin Lispro (hHumalog): An Open-Label, Randomized, Parallel Group, Multi-Center Study in Children and Adolescents with Type 1 Diabetes
    Novo Nordisk
    Role: Principal Investigator
    $61,380
  • January 2003–January 2005
    Norditropin in Children with Growth Failure Associated with IGF Deficiency: A 12 Month, Open-Label, Randomized, Parallel Group, Multi-Center Study in Children and Adolescents with Type 1 Diabetes
    Novo Nordisk
    Role: Principal Investigator
    $44,000
  • January 2003–January 2004
    Morning Lantus (Insulin Glargine [rDNA Origin] Injection) vs. Intermediate-Acting Insulin Twice Daily as Basal Insulin in a Multiple Daily Injection Regimen with Humalog (Insulin Lispro Injection [rDNA Origin]) in Adolescents with Type 1 Diabetes Mellitu
    Aventis Pharmaceuticals
    Role: Principal Investigator
    $31,200
  • January 2003–January 2004
    Endogenous Hormones and Premenopausal Breast Cancer Risk
    NIH/NCI
    Role: Co-Investigator
    $1,411,072
  • January 2003–January 2004
    Basal/Bolus Therapy with Insulin Aspart (Novolog) versus Regular Human Insulin (Novolin R) or Insulin Lispro (Humalog) in Combination with NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents with Type 1 Diabetes
    Novo Nordisk
    Role: Principal Investigator
    $25,650
  • August 2000–July 2003
    Is Type 1 Diabetes Related to Lower Bone Mineral Density in Young Women?
    American Dietetic Association
    Role: Principal Investigator
    $260,871
  • March 2002–February 2003
    Hormonal Milieu and Weight Loss in Obesity
    R.J. Stransky Foundation
    Role: Principal Investigator
    $50,000
  • January 2002–January 2003
    Behavioral and Dietary Modification for Children and Adolescents with Obesity: Effect on Insulin Sensitivity
    Kaleida Health Foundation
    Role: Principal Investigator
    $70,000
  • January 2000–January 2003
    Long Term Safety of Inhaled Human Insulin: Extension of Therapy in Subjects with Type 1 or Type 2 Diabetes Mellitus Completing Phase III Randomized Treatment Trials
    Pfizer
    Role: Principal Investigator
    $208,718
  • January 2002–December 2002
    Multicenter Randomized Double-Blind Trial Combining Six Combination Metformin/Glyburide, Metformin and Glyburide Therapy Titrated to Control in Pediatric Patients with Type 2 Diabetes Mellitus Previously on Insulin Therapy
    Bristol Myers
    Role: Principal Investigator
    $37,500
  • January 1993–January 2002
    Diabetes Prevention Trial -1
    National Institutes of Health
    Role: Principal Investigator
    $31,000,000
  • January 2001–December 2001
    Psychometric Validation of the Pediatric Diabetes Questionnaire and Parents Questionnaire
    Pfizer
    Role: Principal Investigator
    $16,500
  • January 1999–January 2001
    Insulin and Breast Cancer Risk
    Department of the Army
    Role: Co-Investigator
    $238,160
  • January 1999–January 2000
    Efficacy and Safety of Inhaled Compared with Subcutaneous Human Insulin Therapy in Children Ages 6-11 Years with Type 1 Diabetes Mellitus: A Three-Month, Outpatient, Parallel Comparative Trial
    Pfizer
    Role: Principal Investigator
    $61,713
  • January 1999–January 2000
    Efficacy and Safety of Inhaled Compared with Subcutaneous Human Insulin Therapy in Subjects with Type 1 Diabetes Mellitus: A Six-Month, Outpatient, Parallel Comparative Trial
    Pfizer
    Role: Principal Investigator
    $60,764
  • January 1999–January 2000
    A Mutlicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Study of the Efficacy and Safety of Metformin Hydrochloride for the Treatment of Pediatric Subjects with Type 2 Diabetes Mellitus
    Bristol-Myers Squibb
    Role: Principal Investigator
    $7,336
  • January 1999–December 1999
    Type 1 Diabetes and Periodontal Disease
    New York State Health Research Council
    Role: Principal Investigator
    $35,000
  • January 1997–January 1998
    Ultralente versus Pork NPH Insulin in Prepubertal Children with Insulin Dependent Diabetes Mellitus
    Eli Lilly
    Role: Co-Principal Investigator
    $23,000
  • January 1997–December 1997
    Phase III Double Blind, Placebo-Controlled Study of the Effects of Insulin and rhIGF-I in IDDM
    Genentech, Inc.
    Role: Principal Investigator
    $123,800
  • January 1996–December 1996
    A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Multidose Study of the Combined Effects of Subcutaneously Administered Insulin and rhIGF-I in Subjects with Insulin Dependent Diabetes Mellitus
    Genentech, Inc.
    Role: Principal Investigator
    $219,000
  • January 1994–January 1996
    Long Term Monitoring of Safety in Patients Treated with Insulin Analog LY275585
    Lilly Research Laboratories
    Role: Principal Investigator
    $5,025
  • January 1990–January 1995
    Sex Hormones in Neurocognitive Development in Turner Syndrome
    National Institutes of Health
    Role: Consultant
    $244,739
  • January 1993–January 1994
    Evaluation of Safety, Efficacy and Metabolic Effect of Prolonged Subcutaneous Administration of Human Recombinant Insulin-like Growth Factor I in Patients with IDDM
    New York State Health Research Council
    Role: Principal Investigator
    $38,750
  • January 1993–January 1994
    A Phase II, Double Blind Study of the Safety, Efficacy and Metabolic Effects of rhIGF-I in Patients with Type I IDDM and Sub-Optimal Metabolic Control
    Genentech, Inc.
    Role: Principal Investigator
    $114,000
  • January 1993–January 1994
    Insulin Analog LY275585 versus Humulin Regular: Pre-Meal Therapy in New Patients with Type I Diabetes
    Lilly Research Laboratories
    Role: Principal Investigator
    $24,000
  • January 1990–January 1993
    Islet Cell Antibodies and the Natural History of IDDM
    National Institutes of Health
    Role: Principal Investigator
    $3,386,283
  • January 1991–December 1991
    Quantitation of Growth Hormone and Growth Factors in Urine and Blood of Children with IDDM and Controls
    New York State/United University Professions/Governor's Office of Employee Relations
    Role: Principal Investigator
    $730
  • January 1989–December 1989
    Hormonal Control of Fetal, Placental and Infant Growth
    Women and Children's Research Foundation
    Role: Co-Investigator
    $33,500
  • January 1984–January 1985
    Research Training Grant
    Italian Ministry of Public Education
    Role: Principal Investigator
    $22,000
See All (40 Total) >

Journal Articles:
See All (39 Total) >
Abstracts:
  • Shaw N, Liu EY, Lu S, Shine B, Quattrin T. Obese Children Referred to the Pediatric Endocrinologist: Characteristics and Outcome. Pediatr Res. 2003; 53.
  • Desmangles JC, Buchlis JG, Shine B, Quattrin T. Is Metformin a Useful Adjunct to Insulin Therapy in Adolescents with Type 1 Diabetes in Poor Control?. ENDO Meeting Abstracts. 2000.
  • Provias T, Liu G, Monroe J, Wiet M, Unterman S, Quattrin T, Caron J, Carel JC, Shenker A. Incomplete Clinical Penetrance of the Activating M398T Mutation in Helix 2 of the Luteinizing Hormone Receptor (LHR). ENDO Meeting Abstracts. 2000.
  • Desmangles JC, Shine B, Quattrin T. Role of Insulin-like Growth Factor-I in Monitoring GH Therapy in GH Deficient Children. ENDO 2000 Meet the Professor Handouts. 2000.
  • Grossi SG, Donahue RP, Quattrin T, Trevisan M, Ho A, Genco RJ. Periodontal Disease Increase the Risk for Insulin Resistance. J Dent Res. 1999; 78.
  • Quattrin T, Wactawski-Wende J, Dwigun K, Liu J, Donahue RP. Is Diabetes Duration Associated with Lower Bone Mineral Density in Female Teenagers with Type I DM? Preliminary Findings. Diabetes. 1999; 48(Sup 1).
  • Quattrin T, Wactawski-Wende J, Dwigun K, Liu J, Donahue RP. Bone Mineral Density is Normal in Female Teenagers with Longstanding Type 1 Diabetes. Pediatr Res. 1999; 45(4).
  • Ciupak GL, Quattrin T, Shucard JL, Shucard DW. Further Delineation of Cognitive Abilities in Turner Syndrome: Does Estrogen Play a Role?. J Int Neuropsychol Soc. 1997; 3(1).
  • Quattrin T, Thrailkill K, Baker L, Quarmby V, Compton P, Poppenheimer M, Martha PM. Low Plasma Free IGF-I Levels in IDDM: Additional Evidence for a Bi-Hormonal Defect in Diabetes. Diabetes. 1996.
  • Quattrin T, Feld LG, Martha PM. A Single Dose of Recombinant Human IGF-I (rhIGF-I) Does Not Affect Urinary Excretion of Nitric Oxide Metabolites in IDDM. Pediatr Res. 1996; 39.
  • Quattrin T, Ciupak GL, Shucard DW, Shucard JL, Clopper RL, Voorhess ML. Turner Syndrome: Further Delineation of Visual Spatial Abilities and the Role of Estrogen Replacement Therapy. Pediatr Res. 1995; 37(4).
  • Campos SP, Quattrin T, Albini CH, MacGillivray MH. Response of Growth Hormone Therapy in Patients with Insulin Dependent Diabetes Mellitus and Growth Failure. Pediatr Res. 1995; 37(4).
  • Quattrin T, Campos SP, Van Liew JB, Feld LG. Urinary Excretion of Nitric Oxide Metabolites (NO2, NO3) in Subjects with IDDM and Controls. Pediatr Res. 1995; 37(4).
See All (13 Total) >

Professional Memberships:
  • American Academy of Pediatrics
  • American Diabetes Association
  • The Endocrine Society
  • Pediatric Endocrine Society
  • Society for Pediatric Research
  • American Pediatric Society
  • Society for Clinical and Translational Science
  • Association for Psychological Science
  • Medical Society of the State of New York
  • Association of Medical School Pediatric Department Chairs
Presentations:
  • "Enhancing Knowledge of Daycare Personnel on Healthy Weight and Nutrition Using Traditional and Web-based Approaches" Annual Meeting, Pediatric Academic Societies (2013)
  • "Preventing Overweight Starts Early: Buffalo Healthy Tots" International Conference on Obesity and Weight Management, OMICS Group (2012)
  • "Are Children Newly Diagnosed with Type 1 Diabetes Overweight?" 72nd Scientific Sessions, American Diabetes Association (ADA) (2012)
  • "Parent Weight Change Predicts Child Weight Change in Family-based Weight Control Program for Pre-School Children (Buffalo Healthy Tots)" Annual Meeting, Pediatric Academic Societies (2012)
  • "Parent Weight Change Predicts Child Weight Change in Family-based Weight Control Program for Pre-School Children (Buffalo Healthy Tots)" Annual Meeting, Eastern Society for Pediatric Research (2012)
  • "Opening Remarks" 2011 Annual Conference, Turner Syndrome Society (2011)
  • "Treating Pre-School Overweight Children in the Primary Care Setting: Preliminary Results of Buffalo Healthy Tots (BHT)" Annual Meeting, Pediatric Academic Societies/Society for Pediatric Research (2011)
  • "Inhaled Insulin: An Unfinished Story" , Seattle Children's Hospital (2010)
  • "Overweight Epidemic in Children: Early Co-Morbidities Mandate Early Intervention" , Seattle Children's Hospital (2010)
  • "Overweight Epidemic in Children" A. Conger Goodyear Installation Ceremony, University at Buffalo, School of Medicine and Biomedical Sciences (2010)
  • "Higher BMI and Dental Decay May Be Linked" 92nd Annual Meeting, The Endocrine Society (2010)
  • "Insulin and Dopamine in Youth with Obesity" Grand Rounds, Women and Children‘s Hospital of Buffalo (2010)
  • "Obesity and Mortality in Children" News, Channel 4 (2010)
  • "Screening Overweight School-aged Students at High Risk for Impaired Glucose Metabolism in the Buffalo Public Schools" 8th Joint Meeting, Lawson Wilkins Pediatric Endocrine Society/European Society for Pediatric Endocrinology, Global Care in Pediatric Endocrinology (2009)
  • "Insulin and Dopamine in Overweight Youth" Naomi Berrie Diabetes Conference, Columbia University (2009)
  • "Do Insulin or Dopamine Affect Energy Intake?" 90th Annual Meeting, The Endocrine Society (2008)
  • "Dopamine Receptor Genotyping in Children with Short Stature Treated with Growth Hormone Therapy" 90th Annual Meeting, The Endocrine Society (2008)
  • "Inhaled Insulin and Diabetes Management: Clinical Update" Grand Rounds, Women and Children‘s Hospital of Buffalo (2007)
  • "Insulin and Diabetes Management: Clinical Update" Grand Rounds, Golisano Children's Hospital (2007)
  • "Insulin and Diabetes Management: Clinical Update" 6th Elizabeth R. McAnarney Lectureship, Rochester General Hospital (2007)
  • "Evaluating New Options for Treating Type 2 Diabetes" Update for Pharmacists, American Health Resources (2007)
  • "Growth Hormone Therapy in Children Small for Gestational Age" , Saint Barnabas Medical Center (2007)
  • "Type 1 and Type 2 Diabetes in Children and Adolescents: Update" , St. James Mercy Health (2007)
  • "Inhaled Insulin: Clinical Update" XIII Endocrinology and Metabolism Workshop, San Raffaele University (2007)
  • "Growth Hormone Therapy in Children Small for Gestational Age" , Suburban Pediatrics (2006)
  • "Division of Endocrinology/Diabetes: Overview of the Clinical,Teaching and Research Activities" Full-Time Faculty Meeting, University at Buffalo, Department of Pediatrics (2006)
  • "Inhaled Insulin: Clinical Overview" 6th Annual Diabetes Technology Meeting, Diabetes Technology Society (2006)
  • "Diabetes Management at the Women and Children's Hospital of Buffalo: What Are We Doing Well and What Can We Do Better" Grand Rounds, Women and Children‘s Hospital of Buffalo (2006)
  • "Medical Management of the Student with Diabetes" Buffalo District School Nurses, Women and Children‘s Hospital of Buffalo (2006)
  • "Do Stimulants Affect Response to GH Therapy in GH Deficient Children?" 88th Annual Meeting, The Endocrine Society (2006)
  • "MODY 5 Associated with Non-Cyctic Renal Disease and Psoriasis" 88th Annual Meeting, The Endocrine Society (2006)
  • "Pediatric Obesity" Grand Rounds, Catholic Health System, Mercy Hospital (2006)
  • "Type 2 Diabetes" Grand Rounds, Sisters Hospital (2006)
  • "Treating Overweight Youth and Parents in the Pediatrician's Office: Results of a Pilot Study" Annual Meeting, Pediatric Academic Societies (2006)
  • "Pediatric Obesity and Diabetes Current Practice and New Development" Kalamazoo Center for Medical Studies, Michigan State University (2005)
  • "Inhaled Insulin" News, Channel 4 (2005)
  • "Inhaled Insulin Therapy: Efficacy and Safety Data" Annual Meeting, American Association of Pharmaceutical Scientists (2005)
  • "Continuous Quality Improvement Issues in Pediatric Endocrinology and Diabetes" Grand Rounds, Women and Children‘s Hospital of Buffalo (2005)
  • "Insulin Regulation: How to Be Proactive and Improve Diabetes Control" , Sonoma Grille (2005)
  • "Pediatric Obesity: What Can Be Done?" Childhood Obesity, Nutrition, Exercise and Smoking Symposium, American Diabetes Association/Independent Health (2005)
  • "Inhaled Insulin Therapy: Current Development and Future" University Inn Conference Center, University at Buffalo (2005)
  • "Management of Short Stature in Children Born Small for Gestational Age" Speaker Dinner Program, Pfizer Pharmaceuticals (2005)
  • "Diminished Insulin Resistance with Weight Loss in Severely Overweight Youth" 86th Annual Meeting, The Endocrine Society (2004)
  • "Follow-up Data Confirm Low BMD in Young Women with Type 1 Diabetes" 64th Annual Meeting and Scientific Sessions, American Diabetes Association (ADA) (2004)
  • "Insulin-like Growth Factor-I Treatment of Diabetes and Insulin Resistance" 86th Annual Meeting, The Endocrine Society (2004)
  • "Insulin-like Growth Factor-I Treatment of Diabetes and Insulin Resistance" 86th Annual Meeting, The Endocrine Society (2004)
  • "Increasing Obesity in Toddlers: An Emerging Public Health Problem?" Annual Meeting, Pediatric Academic Societies (2004)
  • "Diabetes Mellitus in Children: Update" , Western New York Chapter of Nurse Practitioners (2004)
  • "Inhaled Insulin: Can it Work?" Annual Meeting, Rochester Area Diabetes Educators (2003)
  • "Obesity: From Cells to Society" Community Health Network of Western New York, University at Buffalo, Office of Vice President for Research (2003)
  • "New Insulin Regimes: Their Role in Intensive Insulin Management" Pediatric Grand Rounds, Children's Hospital of Omaha (2003)
  • "Development and Validation of the Parents of Children with Diabetes Questionnaire - A Questionnaire to Assess Treatment Satisfaction and Well-Being" 63rd Annual Meeting and Scientific Sessions, American Diabetes Association (ADA) (2003)
  • "The Obesity Epidemic" New York State Obesity Hearing, University at Buffalo, School of Public Health/School of Medicine and Biomedical Sciences (2003)
  • "Early Childhood Obesity" , MSNBC (2003)
  • "Obese Children Referred to the Pediatric Endocrinologist: Characteristics and Outcome" (2003)
  • "Juvenile Diabetes" Pediatric Grand Rounds, Sisters Hospital (2002)
  • "Efficacy and Safety of Inhaled Insulin (Exubera) Compared to Conventional Subcutaneous Insulin Therapy in Patients with Type 1 Diabetes: Results of a 6-Month Randomized, Comparative Trial" 38th Annual Meeting, European Association for the Study of Diabetes (EASD) (2002)
  • "Obesity in Children" AM Buffalo, WKBW Channel 7 (2002)
  • "Vitamin D" AM Buffalo, WKBW Channel 7 (2002)
  • "Does Lower Bone Mineral Density Start in Post-Teen Years in Women with Type 1 Diabetes?" 62nd Annual Meeting and Scientific Sessions, American Diabetes Association (ADA) (2002)
  • "Efficacy and Safety of Inhaled Insulin (Exubera) Compared to Conventional Subcutaneous Insulin Therapy in Patients with Type 1 Diabetes: Results of a 6-Month Randomized, Comparative Trial" Intervention Expert Panel, Pfizer-Aventis (2002)
  • "Diabetes Management via Continuous Subcutaneous Insulin Infusion: What to do in the School Setting" Annual Meeting, New York State School Nurses (2002)
  • "Efficacy and Safety of Inhaled Insulin (Exubera) Compared to Conventional Subcutaneous Insulin Therapy in Patients with Type 1 Diabetes: Results of a 6-Month Randomized, Comparative Trial" 11th Annual Meeting and Clinical Congress, American Association of Clinical Endocrinologists (AACE) (2002)
  • "Type 1 Diabetes Mellitus" AM Buffalo, WKBW Channel 7 (2002)
  • "Updates on the Clinical and Research Aspects of Diabetes" Support Group, Parents of Diabetics (POD) (2002)
  • "IGF-I Measurement During GH Therapy: Is It Useful?" 6th Joint Meeting, Lawson Wilkins Pediatric Endocrinology Society/European Society for Pediatric Endocrinology (2001)
  • "Screening for Periodontal Disease in Young Patients with Type 1 Diabetes: Preliminary Findings" 61st Scientific Sessions, American Diabetes Association (ADA) (2001)
  • "IGF-I Measurement During GH Therapy: Is It Useful?" Annual Meeting, Society for Pediatric Research (2001)
  • "IGF-I Measurement During Growth Hormone Therapy: Is It Useful?" Annual Meeting, Pediatric Academic Societies (2001)
  • "Fasting Serum Glucose and Insulin and Breast Cancer Risk in Pre-Menopausal and Post Menopausal Women: The ORDET Study" Annual Meeting, American Association of Cancer Research (2001)
  • "Incomplete Clinical Penetrance of the Activating M398T Mutation in Helix 2 of the Luteinizing Hormone Receptor (LHR)" 82nd Annual Meeting, The Endocrine Society (2000)
  • "Is Metformin a Useful Adjunct to Insulin Therapy in Adolescents with Type 1 Diabetes in Poor Control?" 82nd Annual Meeting, The Endocrine Society (2000)
  • "Role of Insulin-like Growth Factor-I in Monitoring GH Therapy in GH Deficient Children" 82nd Annual Meeting, The Endocrine Society (2000)
  • "Potential Optimal Use and Benefit of SomatoKine in Type 1 Diabetes: What Can Be Gained" Diabetes Symposium, Celtrix (1999)
  • "Is Diabetes Duration Associated with Lower Bone Mineral Density in Female Teenagers with Type I DM? Preliminary Findings" 59th Scientific Sessions, American Diabetes Association (ADA) (1999)
  • "Bone Mineral Density is Normal in Female Teenagers with Longstanding Type 1 Diabetes" Annual Meeting, American Pediatric Society/Society for Pediatric Research (1999)
  • "Periodontal Disease Increase the Risk for Insulin Resistance" 77th General Sessions, International Association for Dental Research (1999)
  • "Update on Diabetes Management and Prevention" Pediatric Grand Rounds, Sisters Hospital (1999)
  • "Diabetes Mellitus - Practical Aspects for the Primary Care Physician" Pediatric Residents Conference, Kaleida Health, Women and Children‘s Hospital of Buffalo (1999)
  • "Diabetes Screening and Prevention" Fair, St. John Parish (1999)
  • "Endocrine Research Seminar" Department of Pediatrics, Kaleida Health, Women and Children‘s Hospital of Buffalo (1999)
  • "Type 1 Diabetes: Commitment to Deal with the Present and Hope for the Future" Annual Meeting, Juvenile Diabetes Foundation (JDF), Western New York Chapter (1998)
  • "The Growth Hormone - Insulin-like Growth Factor-I Axis in Type 1 Diabetes: Review and New Developments" Medical Club Meeting, Roswell Park Cancer Institute (1998)
  • "The Growth Hormone - Insulin-like Growth Factor-I Axis in Type 1 Diabetes: Review and New Developments" Grand Rounds, Children‘s Hospital of Birmingham/University of Alabama (1998)
  • "Ambiguous Genitalia" Pediatric Residents Conference, Women and Children‘s Hospital of Buffalo (1998)
  • "Diabetes Management in Children and Adolescents" Grand Rounds, Mercy Hospital (1997)
  • "Advances in the Care of the Pediatric/Adolescent Patient with Diabetes Mellitus" , Women's Christian Association Hospital (1997)
  • "Diabetes in Children and Adolescents" Diabetes Certificate Program, University at Buffalo, School of Pharmacy (1997)
  • "Diabetes in the Child and Adolescent" MiniMed School Program, University at Buffalo, Department of Pharmacology and Toxicology (1997)
  • "Insulin Dependent Diabetes Mellitus: Useful Information for the Pediatric Dentist" Medical Conditions and Considerations of the Pediatric and Adolescent Patient in Regard to Dental Treatment, Catholic Health System (1997)
  • "The F0695g Study: A Phase II Randomized, Double Blind, Placebo-Controlled, Multicenter, Multidose Study of the Combined Effects of Subcutaneously Administered Insulin and rhIGF-I in Subjects with Type I Diabetes Mellitus" Experts Meeting, Roche and Genentech, Inc., rhIGF-I in Diabetes Mellitus: Rationale and State-of-the-Art (1997)
  • "Clinical Experience with Recombinant Insulin-like Growth Factor I (rhIGF-I) in Type II Diabetes Mellitus" Investigator Meeting, Genentech, Inc., Phase III rgIGF-I Studies in Type II Diabetes Mellitus (1997)
  • "Co-Therapy with Recombinant Human Insulin-like Growth Factor I Improves Glycemic Control in IDDM" 57th Scientific Sessions, American Diabetes Association (ADA) (1997)
  • "Effects of Co-Therapy with Recombinant Human Insulin-like Growth Factor I (rhIGF-I) and Insulin on the IGF:IGF Binding Protein (IGFBP) System in IDDM" 79th Annual Meeting, The Endocrine Society (1997)
  • "Recombinant Human IGF-I (rhIGF-I) Imrpoves Metabolic Control in Adolescents and Young Adults with IDDM" Joint Meeting, Lawson Wilkins Pediatric Endocrine Society/European Society for Pediatric Endocrinology (1997)
  • "Screening for Diabetes in Cystic Fibrosis" Lung Center Educational Conference, Women and Children‘s Hospital of Buffalo (1997)
  • "Acarbose in the Treatment of Type 1 Diabetes Mellitus" Endocrinology Journal Club, University at Buffalo (1997)
  • "Growth Hormone and Estrogen Therapy in Turner's Syndrome" Annual Family Meeting, Children's Growth Foundation (1997)
  • "Insulin-like Growth Factor I in Insulin Dependent Diabetes Mellitus: Review and New Developments" Endocrine Grand Rounds, Case Western Reserve University (1997)
  • "Further Delineation of Cognitive Abilities in Turner Syndrome: Does Estrogen Play a Role?" 25th Annual Meeting, International Neuropsychological Society (1997)
  • "Insulin-like Growth Factor I in Type 1 Diabetes: Possible Therapy?" 1996 Research 2000 Lecture Series - Contemporary Diabetes Research Programs, Women and Children's Health Research Foundation of Women and Children‘s Hospital of Buffalo (1996)
  • "Low Plasma Free IGF-I Levels in IDDM: Additional Evidence for a Bi-Hormonal Defect in Diabetes" 56th Annual Scientific Meeting, American Diabetes Association (ADA) (1996)
  • "A Randomized, Double Blind, Placebo-Controlled, Multicenter, Multidose Study of the Combined Effects of Subcutaneously Administered Insulin and rhIGF-I in Subjects with Insulin Dependent Diabetes Mellitus" Initiation Meeting of Protocol, Genentech, Inc. (1996)
  • "Women with Type 1 Diabetes in the 90's" Symposium on Critical Issues in Women's Health, Mercy Health System of Western New York (1995)
  • "Recombinant Human IGF-I Improves Metabolic Control in Adolescents and Young Adults with IDDM" Annual Meeting, European Association for the Study of Diabetes (EASD) (1995)
  • "Effects of Chronic Subcutaneous Insulin-like Growth with Factor-I (IGF-I) Administration on the IGF-I:IGFBP Aberrations in IDDM" 77th Annual Meeting, The Endocrine Society (1995)
  • "Insulin Dependent Diabetes: Current Trends and New Developments" Pediatric Symposium, Roswell Park Cancer Institute (1995)
  • "Turner Syndrome: Further Delineation of Visual Spatial Abilities and the Role of Estrogen Replacement Therapy" Annual Meeting, American Pediatric Society/Society for Pediatric Research (1995)
  • "Double Blind Study of Safety, Efficacy and Metabolic Effects of Insulin-like Growth Factor I in Type 1 Diabetes" Interdisciplinary Vascular and Metabolic Research Group, Millard Fillmore Hospital (1995)
  • "Phase II Double Blind Study of the Safety, Efficiency and Metabolic Effects of IGF-I in IDDM" Research Conference, Women and Children‘s Hospital of Buffalo (1995)
  • "Review of the Diabetes Control Complication Trial: Implications for the Nutritionist" Western New York Chapter of Registered Dietitians, Women and Children‘s Hospital of Buffalo (1995)
  • "Care Map Use and Implementation" Grand Rounds, Women and Children‘s Hospital of Buffalo (1995)
  • "Auditory Evoked Potentials and Verbal and Spatial Abilities in Preadolescent Children" Annual Meeting, Society for Neuroscience (1994)
  • "Diabetes Control ComplicationsTrial: What Does It Mean?" Grand Rounds, Women and Children‘s Hospital of Buffalo (1994)
  • "Growth Hormone, IGF-I and IGFI BP-3 in Patients with Cystic Fibrosis" 76th Annual Meeting, The Endocrine Society (1994)
  • "Implementing the Findings of the Diagnostic Control and Complication Trial" Annual Meeting, Society for Pediatric Research/Lawson Wilkins Pediatric Endocrine Society, Combined Scientific Session (1994)
  • "Outpatient Management of Diabetic Patients" Grand Rounds, South Buffalo Mercy Hospital (1994)
  • "The Management of the Surgical Patient with Insulin Dependent Diabetes Mellitus" Surgery Grand Rounds, Women and Children‘s Hospital of Buffalo (1993)
  • "High Prevalence of Low Plasma IGF-I Levels in Children and Adolescents with Insulin Dependent Diabetes Mellitus" 4th Joint Meeting, Lawson Wilkins Pediatric Endocrine Society/European Society for Pediatric Endocrinology (1993)
  • "Diabetes Ketoacidosis: Clinical Aspects and Treatment" Current Issues in Pediatric Endocrinology and Diabetes: Medical and Psychoendocrine Perspectives, University at Buffalo (1993)
  • "Follow-up Study of an Adolescent Population with Diabetes Screened for Microalbuminuria" Annual Meeting, Eastern Society for Pediatric Research (1992)
  • "Serum Creatinine and Height Do Not Predict Glomerular Filtration Rate in Children with Insulin Dependent Diabetes Mellitus" Annual Meeting, Eastern Society for Pediatric Research (1992)
  • "Prospective Study of Plasma and Urinary IGF-I and IGF-II in Children with Diabetes" 74th Annual Meeting, The Endocrine Society (1992)
  • "Update on Insulin Dependent Diabetes and Its Complications" Grand Rounds, Women and Children‘s Hospital of Buffalo (1992)
  • "Management of the Adolescent with Diabetes Mellitus: A Challenge for Both Patients and Physicians" Pediatric Update (1991)
  • "Comparison of Enzyme Linked Immunosorbent Assay (Elisa) versus Radioimmunoassay (RIA) Methods for Quantitation of Urinary Growth Hormone (GH) Output" 73rd Annual Meeting, The Endocrine Society (1991)
  • "Low Urinary IGF-I and IGF-II Excretion in Children with GH Deficiency and Subjects with Idiopathic Short Stature" 73rd Annual Meeting, The Endocrine Society (1991)
  • "Urinary IGF-I and IGF-II Output in Newly Diagnosed IDDM Children and in Normal Controls" International Study Group of Diabetes in Children and Adolescents, American Diabetes Association (1991)
  • "Insulin and Sodium Sensitivity: Preliminary Findings of a Clinical Trial" 31st Annual Conference on Cardiovascular Disease Epidemiology, American Heart Association (1991)
  • "Update on IDDM Management" Pediatric Grand Rounds, South Buffalo Mercy Hospital (1991)
  • "Diabetes Ketoacidosis" Grand Rounds, Sisters Hospital (1991)
  • "Effects of Growth Hormone (GH) Treatment Schedule on Urinary GH and Insulin-like Growth Factor I (IGF-I) Output During Thrice Weekly vs. Daily Administration" 72nd Annual Meeting, The Endocrine Society (1990)
  • "Urinary Insulin-like Growth Factor II (IGF-II) and Insulin-like Growth Factor I (IGF-I) Excretion in Health Infants and Children" 72nd Annual Meeting, The Endocrine Society (1990)
  • "Correlation Between Serum and Urinary Growth Hormone" 71st Annual Meeting, The Endocrine Society (1989)
  • "Urinary Excretion of Growth Hormone (GH) and Insulin-like Growth Factor I (IGF-I) is Small for Gestational Age, Preterm and Full Term Infants and Children" 70th Annual Meeting, The Endocrine Society (1988)
  • "Urinary Excretion of Insulin-like Growth Factor I (IGF-I) in Pregnancy" 70th Annual Meeting, The Endocrine Society (1988)
  • "Quantitation of Urinary Growth Hormone (GH) and Somatomedin-C (SMC/IGF-I) in Children with Normal and Abnormal Growth" International Symposium on Growth Hormone, Serono Symposia, USA (1987)
  • "Central and Peripheral Stimulation of Puberty in McCune Albright Syndrome: Multiadenomatosis?" XLIII Meeting, Italian Society of Pediatrics (1986)
  • "Neonatal Transitory Diabetes Mellitus: Case Report" V Meeting, Italian Society of Pediatric Endocrinology and Diabetology (1985)
  • "Prognostic Signs in the Evolution of Premature Thelarche (PT)" 2nd Joint Meeting, Lawsome Wilkins Pediatric Endocrine Society/European Society for Pediatric Endocrinology (1985)
  • "Growth and Maturational Responses to Thyroid Hormones" 23rd Annual Meeting, European Society for Pediatric Endocrinology (1984)
  • "Variability in the Time of Disappearance of Some Manifestations of Congenital Hypothyroidism" Prime Giornate Italiane della Tiroide (1983)
  • "Exogenous Infantile Obesity: A Clinical and Social Problem" IV Meeting, Italian Society of Pediatric Endocrinology and Diabetology (1983)
  • "Thyroid Function in Children with Phenylketonuria (PKU)" IV Meeting, Italian Society of Pediatric Endocrinology and Diabetology (1983)
See All (144 Total) >
Service Activities:
  • School of Medicine & Biomedical Sciences Faculty Council; Chair (2007)
  • School of Medicine & Biomedical Sciences Faculty Council; Department Representative (1995–1998)
  • American Diabetes Association: 71st Scientific Session; Reviewer (2011)
  • Greeley Company Seminar: Mastering Medical Leadership (Boca Raton, FL); Invited Participant (2010)
  • Ibsen: Potential Applications of IGF-I in the Treatment of Type 2 Diabetes; Medical Science Advisory Board Member (2010)
  • American Pediatric Society: 2010 Meeting Workshop; Reviewer (2010)
  • Italian Ministry of Health: Expert Grant Reviewer Panel for "Young Italian Researchers Call"; Grant Reviewer (2010)
  • Novo Nordisk: Pediatric Diabetes Consultant Meeting (Miami, FL); Invited Participant (2009)
  • University at Buffalo Associates; Board of Directors (2009–2010)
  • University at Buffalo: Clinical and Translational Research Center Internal Advisory Council; Member (2009)
  • Pfizer Pharmaceuticals: Pediatric Endocrinology Advisory Board Meeting (New York, NY); Advisory Board (2008)
  • University at Buffalo: Commission of Academic Excellence and Equity; Member (2008–2012)
  • UBMD Management Council: Contracting Committee; Chair (2008–2009)
  • Seneca Diabetes Foundation; Dr. Quattrin was instrumental in the establishment of this endowed chair. Interest generated each year will be devoted to conduct research and provide health care professional support to the diabetic children with type 2 diabetes in the Seneca Nation and Western New York.; Chair (2007)
  • Seneca Diabetes Foundation; Board of Directors (2007)
  • University at Buffalo: Clinical Science Panel; UB Interdisciplinary Research Development Fund; Panel Member (2007)
  • Independent Health: Inhaled Insulin; Medical Advisory Panel Member (2006)
  • American Heart Association; Invited Speaker (2005)
  • Seneca Diabetes Foundation; Board Member (2005)
  • Women and Children‘s Hospital of Buffalo: Medical Advisory Committee; Committee Member (2005–2006)
  • Tercica: IFG-I Studies (Increlex); U.S. Advisory Board Member (2005)
  • Children's Growth Foundation; Board Member (2004)
  • University at Buffalo School of Medicine and Biomedical Sciences: Quality Improvement Projects; in collaboration with Independent Health - includes Idealized Design of the Clinical Office Practice; Participant (2004)
  • Pfizer Pharmaceuticals: International Experts Meeting (San Francisco, CA); "Inhaled Insulin"; Invited Participant (2002)
  • Novo Nordisk: Consultant Meeting (Washington, DC); Invited Participant (2002)
  • National Institutes of Health: Site Visit for Re-accreditation of the University of North Carolina GCRC; Reviewer (2002)
  • Aventis Pharmaceuticals: Consultant Meeting (Philadelphia, PA); Invited Participant (2001)
  • Celtrix Pharmaceuticals: National Diabetes Symposium; "Phase II Trials with Somatokine (IFG-I/BP-3) in Diabetes"; Invited Participant (2000)
  • Aventis Pharmaceuticals: Consultant Meeting (Buffalo, NY); Invited Participant (2000)
  • Kaleida Health: Medical/Dental Staff Ad Hoc Hearing Committee; Committee Member (2000)
  • University at Buffalo School of Medicine and Biomedical Sciences: Medical Student Career Night "Sharing Careers and Lifestyles"; Small group breakout sessions for specialty areas; Participant (1998)
  • Juvenile Diabetes Foundation (JDF): Western New York Chapter - Insulin Pump Workshop; Invited Participant (1998)
  • Brooks Memorial Hospital: Diabetes Support Group; Invited Speaker (1997)
  • Roche and Genentech, Inc.: International Experts Meeting; "rhIGF-I in Diabetes Mellitus: Rationale and State-of-the-Art"; Invited Participant (1997)
  • George Washington University Biostatistics Center: Consensus Panel; "Diabetic Retinopathy and rhIGF-I Therapy in Diabetes Mellitus"; Panel Member (1996)
  • Genentech, Inc.: National Experts Planning Session; For the Development of Studies on the Use of Recombinant Human Insulin-like Growth Factor I in Insulin Dependent Diabetes Mellitus; Invited Participant (1995)
  • University at Buffalo: Center for the Study of Biobehavioral and Social Aspects of Health - Site Visit and Presentation; For renewal of funding from SUNYAB; Participant (1995)
  • University at Buffalo: Multidisciplinary (working) Committee; Outcome project in the area of diabetes (funded through a demonstration of the New York State Department of Health); Committee Member (1994–1996)
  • University Pediatric Associates, Inc.: Benefits Committee; Committee Member (1994)
  • Eastern Society for Pediatric Research: Section of Endocrinology; Moderator (1993)
  • University at Buffalo: Center for the Study of Biobehavioral and Social Aspects of Health - Seminary Planning Committee; Planning of programs, selection of speakers and abstracts for 5 interdisciplinary meetings/year; Committee Member (1993–1995)
  • American Diabetes Association (ADA): Patient Education Day at Medaille College (Buffalo, NY); Invited Speaker (1992)
  • Gateway Youth and Family Services: Women's History Month; Presented to staff and children; Invited Participant (1992)
  • American Diabetes Association (ADA): Camp Sunshine Committee (Rochester, NY); Committee Member (1991–2010)
  • American Diabetes Association (ADA): Western New York Chapter; Board of Directors (1991–2000)
  • Juvenile Diabetes Foundation (JDF): Western New York Chapter; Annual presentation to update members regarding clinical/research activities of the Diabetes Center; Board of Directors (1991–1993)
  • American Diabetes Association (ADA): Western New York Chapter; Fund Raiser (1991)
  • Juvenile Diabetes Foundation (JDF): Western New York Chapter; Fund Raiser (1991)
  • University at Buffalo School of Medicine and Biomedical Sciences: Development of Care Maps for Diabetes Care; Member (1990–1997)
  • American Diabetes Association: Annual Meeting (2005, 2006); Reviewer
  • American Journal of Obstetric and Gynecology; Reviewer
  • Archives of Disease in Childhood; Reviewer
  • Clinical Pediatrics; Reviewer
  • Diabetes Care; Reviewer
  • Diabetes Research and Clinical Practice; Reviewer
  • Diabetes Technology and Techniques; Reviewer
  • Diabetologia (Journal of the European Association for the Study of Diabetes); Reviewer
  • Drug Evaluations (New Zealand); Reviewer
  • Drug Profiles (United Kingdom); Reviewer
  • Endocrine Practice; Reviewer
  • Endocrinology; Reviewer
  • European Journal of Clinical Investigation; Reviewer
  • Expert Opinion on Drug Delivery (United Kingdom); Reviewer
  • Expert Review of Endocrinology and Metabolism; Reviewer
  • Insmed Incorporated: Planning Studies on Insulin-like Growth Factor -1/Binding Protein 3 (Iplex) (2005-2006); U.S. Advisory Board Member
  • Insulin; Reviewer
  • International Archives of Allergy and Immunology; Reviewer
  • Journal of Clinical Endocrinology and Metabolism; Reviewer
  • Nature Clinical Practice Endocrinolgy and Metabolism; Reviewer
  • Pfizer Pharmaceuticals: Development of Studies on Inhaled Insulin in Pediatrics (2005-2006); International Advisory Board Member
  • Tercica: Development of rhInsulin-like Growth Factor 1 in Children with Short Stature (2005-2006); Consultant
  • The Lancet; Reviewer
  • The Open Pediatrics Medical Journal; Editorial Board Member
  • Type 1 Diabetes Trial Net: Steering Committee (2006-2007); Committee Member

Clinical Specialties:
Clinical Offices:
Insurance Accepted:

bottom-left cornerbottom-right corner

Contact Information

Women and Children‘s Hospital of Buffalo
Department of Pediatrics
239 Bryant Street
Buffalo, NY 14222
Phone: (716) 878-7300
Fax: (716) 878-7339
Email: quattrin@buffalo.edu

Patient Care

Looking for a doctor? This faculty member is affiliated with UBMD, the group comprised of practicing physicians who are also professors in the UB School of Medicine and Biomedical Sciences.

View this faculty on UBMD

Log in to Update Your Profile
"); pageTracker._trackPageview();